- Fund Type: Open-End Fund
- Objective: Region Fund-European
- Asset Class: Equity
- Geographic Focus: European Region
Snapshot for AL Trust Aktien Europa (ALTLAKE)
| Year To Date: | +8.56% | 3-Month: | +10.35% | 3-Year: | +5.80% | 52-Week Range: | 31.50 - 42.91 |
|---|---|---|---|---|---|---|---|
| 1-Month: | +11.12% | 1-Year: | +34.71% | 5-Year: | -3.84% | Beta vs DJST: | 0.93 |
Fund Profile & Information for ALTLAKE
AL Trust Aktien Europa is an open-end investment fund incorporated in Germany. The Fund's objective is income and growth. The Fund invests in European stocks.
| Inception Date: | 03-01-1999 | Telephone: | 49-6171-6667 |
|---|---|---|---|
| Managers: | BERNHARD DOEHLER | ||
| Web Site: | www.alte-leipziger.de | ||
Fundamentals for ALTLAKE
| NAV | (on 2013-05-21) 42.86 |
|---|---|
| Assets (M) | (on 2013-05-21) 22.21 |
| Fund Leveraged | N |
| Minimum Investment | - |
| Minimum Subsequent Investment | - |
Dividends for ALTLAKE
| Dividend Type | Income |
|---|---|
| Dividend Frequency | Annual |
| Last Dividend Net | (on 2012-11-23) 0.79 |
| Dividend Yield (ttm) | 1.84 |
Fees & Expenses for ALTLAKE
| Front Load | 4.76 |
|---|---|
| Back Load | 0.00 |
| Current Mgmt Fee | 1.50 |
| Redemption Fee | 0.00 |
| 12b1 Fee | - |
| Expense Ratio | 1.64 |
Top Fund Holdings for ALTLAKE
Filing Date: 04/30/2013| Name | Position | Value | % of Total |
|---|---|---|---|
| Sanofi | 14,319 | 1,189,766 | 5.597% |
| Total SA | 26,266 | 996,532 | 4.688% |
| Bayer AG | 9,871 | 787,607 | 3.705% |
| Siemens AG | 9,854 | 781,225 | 3.675% |
| BASF SE | 10,946 | 775,524 | 3.648% |
| Banco Santander SA | 122,531 | 677,229 | 3.186% |
| SAP AG | 10,997 | 660,810 | 3.108% |
| Anheuser-Busch InBev NV | 8,748 | 619,796 | 2.915% |
| Allianz SE | 5,365 | 605,440 | 2.848% |
| Unilever NV | 18,654 | 601,312 | 2.829% |
Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
- 1
- 2
- 3
- 4
- 5
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page